GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » Capex-to-Operating-Income

Cangene (FRA:YGE) Capex-to-Operating-Income : 0.00 (As of Oct. 2013)


View and export this data going back to . Start your Free Trial

What is Cangene Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Cangene's Capital Expenditure for the three months ended in Oct. 2013 was €-0.03 Mil. Its Operating Income for the three months ended in Oct. 2013 was €-2.99 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.


Cangene Capex-to-Operating-Income Historical Data

The historical data trend for Cangene's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene Capex-to-Operating-Income Chart

Cangene Annual Data
Trend Jul04 Jul05 Jul06 Jul07 Jul08 Jul09 Jul10 Jul11 Jul12 Jul13
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.18 1.68 1.89 - 0.28

Cangene Quarterly Data
Jan09 Apr09 Jul09 Oct09 Jan10 Apr10 Jul10 Oct10 Jan11 Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13 Oct13
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 0.08 0.67 -

Competitive Comparison of Cangene's Capex-to-Operating-Income

For the Biotechnology subindustry, Cangene's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cangene's Capex-to-Operating-Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cangene's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Cangene's Capex-to-Operating-Income falls into.



Cangene Capex-to-Operating-Income Calculation

Cangene's Capex-to-Operating-Income for the fiscal year that ended in Jul. 2013 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-2.448) / 8.65
=0.28

Cangene's Capex-to-Operating-Income for the quarter that ended in Oct. 2013 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-0.032) / -2.992
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cangene  (FRA:YGE) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Cangene Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Cangene's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Cangene (FRA:YGE) Business Description

Traded in Other Exchanges
N/A
Address
Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines